Markets

HIVE Digital Technologies is expanding its Paraguay site with a 100 MW hydroelectric-powered Phase 3, bringing the site’s capacity to 400 MW and HIVE’s global renewable energy footprint to 540 MW. The company aims to reach 35 EH/s Bitcoin mining capacity by 2026, with Phase 3 construction starting in early 2026 and commissioning in Q3 2026. HIVE has also partnered with Bell Canada to integrate BUZZ HPC AI infrastructure, projecting a 5x growth in HPC/AI capacity by 2026, driven by GPU clusters and a Toronto buildout.

On October 20-21, 2025, Carbon Streaming Corporation (OFSTF) CEO Marin Katusa purchased 74,500 common shares at $0.67 per share, totaling $49,915. This increased his holdings to 4,175,500 shares, representing approximately 8.6% of outstanding shares. If his warrants are exercised, his ownership would be near 10.8%. The purchase was for investment purposes, with potential for further transactions. The Early Warning Report is available on SEDAR+.

First Trust Senior Floating Rate Income Fund II (FCT) announced a monthly distribution of $0.097 per share, payable November 17, 2025, to shareholders of record on November 3, 2025. The distribution rate is 11.26% based on the October 17 NAV and 12.01% based on the closing market price. FCT primarily invests in senior secured floating-rate corporate loans, aiming for high current income and capital preservation. Investors should consider the risks associated with lower-grade, high-yield securities and senior loans, as well as the fund’s potential NAV reduction over time.

Flexsteel Industries (FLXS) reported strong first quarter fiscal 2026 results, with net sales up 6.2% to $110.4 million and GAAP net income per diluted share increasing to $1.31. The company attributed the growth to effective product offerings and strategic investments. CEO Derek Schmidt acknowledged ongoing challenges, including tariffs on imported timber which are projected to impact sales and profitability short-term. The company ended the quarter with a strong liquidity position, including $38.6 million in cash. A conference call to discuss the results will be held on October 21, 2025.

Sunoco LP (SUN) announced a quarterly distribution of $0.9202 per common unit, an annualized rate of $3.6808. This represents a 1.25% increase from the previous quarter, marking the fourth consecutive quarterly rise. The distribution, payable November 19, 2025, reflects Sunoco’s commitment to shareholder value and disciplined capital allocation, aligning with its targeted annual distribution growth of at least 5%. Sunoco’s diversified operations and extensive infrastructure across multiple states contribute to its stable performance. Investors should consider inherent risks associated with MLPs, including economic and regulatory factors.

Sokoman Minerals is expanding its land position along Newfoundland’s Valentine Lake Fault through property acquisitions and option agreements. They’re acquiring 100% of the Keats Property via cash, shares, and an NSR, retaining the option to repurchase half the NSR. They’ve also secured an option to acquire 100% of the Stony Lake Property by issuing shares and funding exploration. Underwriters also have the option to purchase additional flow-through shares generating potential further gross proceeds. This consolidation underscores Sokoman’s belief in significant resource potential.

10x Genomics and Anthropic have partnered to integrate 10x’s analysis tools into Anthropic’s Claude for Life Sciences via the Model Context Protocol (MCP). This allows researchers to use natural language to explore single-cell and spatial biology datasets, democratizing access to advanced analysis that previously required computational expertise. Scientists can now leverage Claude for tasks like data alignment and clustering through a conversational interface, accelerating research and broadening adoption of 10x Genomics’ technologies. The collaboration aims to unlock new insights and accelerate scientific discovery by combining AI with biological data analysis.

Altisource Portfolio Solutions (ASPS) will announce its third quarter 2025 financial results on Thursday, October 23, 2025. A press release and presentation will be available on the company’s Investor Relations website. A live conference call and audio webcast will be held at 8:30 a.m. EDT on the same day. Registration on the Investor Relations website is required prior to the webcast, and a replay will be available approximately two hours after the call’s conclusion, accessible for about 30 days.

Rapid Dose Therapeutics (RDTCF) extended its agreement with an international partner to evaluate its NicStrip™ oral thin film nicotine delivery system. The seven-month extension is valued at $1.8M CAD. RDT filed for Health Canada approval for NicStrip™ in multiple dosages and initiated a clinical study comparing it to traditional cigarettes. Two patent applications were filed covering dissolvable and non-dissolvable formats. NicStrip™ targets adult consumers seeking smoke-free alternatives. Market trends show significant growth in nicotine pouches and other modern oral nicotine products.

Summit Therapeutics plans a Q4 2025 BLA submission for ivonescimab plus chemotherapy in EGFR-mutated NSCLC based on positive Phase III HARMONi trial results. A new Phase III CRC study (HARMONi-GI3) will begin, with more Phase III trials planned. HARMONi showed a 48% reduction in disease progression risk in NSCLC and the HARMONi-6 study in China demonstrated a 40% reduction in risk in squamous NSCLC compared to tislelizumab plus chemotherapy. The HARMONi-3 study will analyze squamous and non-squamous NSCLC cohorts separately.